Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 5Recruiting 3Unknown 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Breast Neoplasms 5Neoplasms 4Ovarian Neoplasms 2Motor Activity 2Fallopian Tube Neoplasms 2Uncertainty 1Polyps 1Pancreatic Neoplasms 1Palliative Care 1Pain 1Obesity 1Neoplasm Metastasis 1Lung Neoplasms 1Knee Tumor 1Inflammation 1Head and Neck Neoplasms 1Depression 1Critical Illness 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Brenner Tumor 1Breast Carcinoma In Situ 1Breast Cancer Lymphedema 1Adenoma 1

Interventions

Carboplatin 84Cisplatin 80Pemetrexed 72Docetaxel 60Gemcitabine 43Drug Therapy 43Erlotinib Hydrochloride 42Gefitinib 38Radiotherapy 36Paclitaxel 36pembrolizumab 31Bevacizumab 29icotinib 28osimertinib 27anlotinib 26Nivolumab 24camrelizumab 23Vinorelbine 23Radiosurgery 20aumolertinib 18atezolizumab 17sintilimab 16apatinib 16Endostatins 16endostar protein 15durvalumab 13Surgical Procedures, Operative 13Immunotherapy 12Immune Checkpoint Inhibitors 12Blood Specimen Collection 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Carcinoma, Non-Small-Cell Lung × Methods × Clear all
NCT03594682 2018-07-20

Optimizing the Therapeutic Dose of Apatinib Mesylate Tablets in Patients With Lung Cancer by Dose Titration:A Real World Exploratory Study

Beijing Chest Hospital

Phase NA Unknown
31 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡